GSK Investigational Site

Sorocaba, São Paulo 18040-425

0 studies enrolling now · 2 studies all time

What they study most

Hypereosinophilic Syndrome

Studies at this site

• A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 — Completed
• Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) — Completed